Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH — Clinical Trial Site

29 Registered trials

16 Currently recruiting

Organisation

Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH

Location

Bochum, Germany

Identifier

ORG-100020127

Address

In Der Schornau 23-25, Langendreer, 44892, Germany

Departments

Abteilung für Gastroenterologie, Onkologie, Hepatologie
Department of Anaesthesiology, Intensive Care Medicine
Department of Hematologie
Department of Hematology
Department of Neurology
Gastroenterologie & Hepatologie , Medizinische Klinik
Hematology
Hematology/Oncologic clinic
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie
Klinik für Chirurgie
Klinik für Hämatologie, Stammzelltransplantation und Zelltherapie
Klinik für Neurologie
Knappschaftskrankenhaus
Medizinische Klinik
Medizinische Universitätsklinik
N/A
NA
Neurologie
Neurologische Klinik
Neurology
Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH

Clinical trials at this site (29)

Search interface

A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting

2024-512753-24-00 Acute Myeloid Leukemia (AML) 5 2025-08-05
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
Early Sedation with Dexmedetomidine vs. Placebo in Older Ventilated Critically Ill Patients Recruiting

2022-501157-36-00 Critically ill patients who are dependent on high level 6 2024-02-07
A Randomized, Placebo‐Controlled Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Adult Patients With Newly Di… Recruiting

2023-507518-28-00 Acute myeloid leukemia 5 2022-09-13
Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants Recruiting

2025-521762-99-00 acute ischemic stroke 5 2026-03-09
Registry and clinical trial comparing standard intensity and reduced intensity treatment in patients with AML or CLL who do not have residua… Recruiting

2024-512503-39-00 Arm A (AML): Newly diagnosed de novo Acute myeloid leuk 6 2025-12-19
A study to investigate the safety and efficacy of GSK4532990 compared with placebo in adult participants aged 18 to 65 years with alcohol-re… Recruiting

2024-511596-15-00 Liver Diseases, Alcoholic 4 2024-12-26
Lomustine with or without a second round of brain radiation for the reappearance of glioblastoma Recruiting

2023-505267-36-00 Glioblastoma 5 2024-03-15
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line tr… Recruiting

2024-512320-11-00 Primary diffuse large B-cell lymphoma of the central ne 5 2023-08-09
A multicentre, randomized trial in adults with de novo Philadelphia-Chromosome positive acute lymphoblastic leukemia to assess the efficacy … Recruiting

2024-517966-40-00 Acute lymphoblastic leukemia (ALL), de novo, Ph/BCR::AB 4 2023-07-13
Cholangiocarcinoma treatment with radiofrequency ablation or photodynamic therapy Recruiting

2022-500107-50-00 hilar cholangiocarcinoma 6 2022-10-12
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy (MecMeth/ NOA-24) Recruiting

2024-511264-89-00 Glioblastoma 4 2022-04-11
The ABC-HCC Trial: A Phase IIIb, randomized, multicenter, open-label trial of Atezolizumab plus Bevacizumab versus transarterial Chemoemboli… Recruiting

2024-512953-26-00 intermediate-stage hepatocellular carcinoma 5 2021-07-06
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 glioma with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-… Recruiting

2024-510616-73-00 newly diagnosed WHO grade 2 or 3 glioma 5 2020-12-16
Prospective, randomized study concerning personalized medicine with Pentaglobin® after interventional infectious source control in peritonit… Recruiting

2024-513526-27-00 secondary or quaternary peritonitis 4 2018-02-23
Multicentre, open-label, randomised, two-arm, parallel-group, superiority trial to assess bioavailability and practicability of two once-dai… Ended

2023-503531-18-00 Prophylaxis of transplant rejection in adult kidney all 6 2024-02-13
A prospective multicenter phase 2 study of the chemotherapy-light combination of intravenous rituximab with the antibody-drug conjugate pol… Ended

2024-513949-37-00 previously untreated aggressive B-cell lymphoma 4 2023-03-16
DALY 2-EU Ended

2023-506270-13-00 Relapsed/refractory diffuse large B cell lymphoma (R-R 4 2021-07-27
Research study on whether semaglutide works in people with non-alcoholic steatohepatitis (NASH) Ended

2023-506962-30-00 Non-alcoholic steatohepatitis (NASH) 5 2021-03-29
Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined… Ended

2024-511577-29-01 intermediate and high-risk rectal cancer 5 2020-03-13
HOVON 156 AML: Treatment for acute myeloid leukemia (AML) or myelodysplastic syndrome with a FLT3 mutation with gilteritinib or midostaurin … Ended

2022-502478-18-00 Acute Myeloid Leukemia (AML) 4 2019-12-20
Randomized Phase III Study of Standard Intensive Chemotherapy versus Intensive Chemotherapy with CPX-351 in Adult Patients with Newly Diagno… Ended

2023-503670-21-00 Patients with newly diagnosed AML and intermediate- or 5 2019-08-28
Treatment for previously untreated patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an IDH1 or IDH2 mutatio… Ended

2022-502832-37-00 Acute myeloid leukemia 5 2019-03-01